Andrew Doodnauth
Internal Medicine · Brooklyn, NYNPI 1639630569
Payments from drug & device makers
Across 120 payments — averaging $103.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$5K
- Medtronic$4K
- Kestra Medical Technology Services, Inc.$798
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$796
- Boston Scientific$606
- Scpharmaceuticals Inc.$425
- plus $1K from 14 others
What the payments were for
- Grants$7,83363%
- Food & beverage$4,49436%
- Education$590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 7 | $4,799 |
| Medtronic | 5 | $3,520 |
| Kestra Medical Technology Services, Inc. | 11 | $798 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 26 | $796 |
| Boston Scientific | 22 | $606 |
| Scpharmaceuticals Inc. | 5 | $425 |
| Alnylam Pharmaceuticals Inc. | 7 | $295 |
| AstraZeneca | 10 | $183 |
| Impulse Dynamics (USA) Inc. | 2 | $169 |
| Johnson & Johnson | 2 | $155 |
| Nuwellis, Inc. | 1 | $146 |
| Novartis | 6 | $140 |
| Actelion Pharmaceuticals US, Inc. | 3 | $81 |
| Pfizer | 4 | $78 |
| Merck | 3 | $60 |
| Sanofi-aventis U.S. LLC | 1 | $36 |
| Biotronik Inc. | 2 | $31 |
| Lexicon Pharmaceuticals, Inc. | 1 | $24 |
| Abiomed | 1 | $24 |
| Biosense Webster, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ASSURITY$2,625
- TACTICATH$1,875
- Assure WCD$590
- OPTIMIZER$266
- FUROSCIX$245
- AQUADEX SMARTFLOW CONSOLE$146
- Farapulse$128
- AMVUTTRA$125
- XARELTO$125
- Micra$123
- CARDIOMEMS$123
- GENERAL TACHY$107
- GALLANT$104
How this compares
$12,386 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 49 | $47,149 |
| FarxigaDapagliflozin Propanediol | 47 | $32,895 |
| EliquisApixaban | 27 | $19,853 |
| JardianceEmpagliflozin | 16 | $11,870 |
| Metoprolol Succinate | 80 | $696 |
| Rosuvastatin Calcium | 71 | $614 |
| Ezetimibe | 21 | $558 |
| Isosorbide Dinitrate | 20 | $451 |
| Valsartan | 24 | $261 |
| Chlorthalidone | 24 | $251 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 19 | $192 |
| Nifedipine ErNifedipine | 17 | $184 |
| Atorvastatin Calcium | 32 | $127 |
| Spironolactone | 43 | $98 |
| Glipizide ErGlipizide | 12 | $75 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $140 | $47,14949 claims |
| AstraZenecaFarxiga | $183 | $32,89547 claims |
| PfizerEliquis | $78 | $19,85327 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Brooklyn
- Bruce BergerBrooklyn$3.4M
- Nelly CohenBrooklyn$2.8M
- Jorge SerjeBrooklyn$1.3M
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.